Skip to content
LexBuild

Notice of HIDTA Designations

---
identifier: "/us/fr/2014-24176"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of HIDTA Designations"
title_number: 0
title_name: "Federal Register"
section_number: "2014-24176"
section_name: "Notice of HIDTA Designations"
positive_law: false
currency: "2014-10-10"
last_updated: "2014-10-10"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "2014-24176"
document_type: "notice"
publication_date: "2014-10-10"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "79 FR 61341"
fr_volume: 79
---

#  Notice of HIDTA Designations

*Heading:* Designation of 26 Counties/Cities as High Intensity Drug Trafficking Areas.

**SUMMARY:**

The Director of the Office of National Drug Control Policy designated 26 additional counties/cities as High Intensity Drug Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties/cities are (1) Madison and Nelson Counties in Kentucky, Tazewell County in Virginia, and Harrison County in West Virginia as part of the Appalachia HIDTA; (2) Pasco County in Florida as part of the Central Florida HIDTA; (3) Trinity and Siskiyou Counties in California as part of the Central Valley California HIDTA; (4) Brazoria County in Texas as part of the Houston HIDTA; (5) Rockingham County in New Hampshire as part of the New England HIDTA; (6) Chautauqua, Dutchess, Putnam, and Rockland Counties in New York as part of the New York/New Jersey HIDTA; (7) Ada and Canyon Counties in Idaho, and Malheur County in Oregon as part of the Oregon HIDTA; (8) Gallatin County in Montana as part of the Rocky Mountain HIDTA; (9) Potter and Randall Counties in Texas as part of the Texoma HIDTA; and (10) Berkeley County in West Virginia and the Cities of Chesapeake, Hampton, Newport News, Norfolk, Portsmouth, and Virginia Beach in Virginia as part of the Washington/Baltimore HIDTA.

**FOR FURTHER INFORMATION CONTACT:**

Questions regarding this notice should be directed to Michael K. Gottlieb, National HIDTA Program Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 395-4868.

Submitted October 6, 2014.

Dated: September 29, 2014.

Daniel Rader,

Deputy General Counsel.